MX370297B - Procedimientos de diálisis de anticoagulación regional con citrato. - Google Patents

Procedimientos de diálisis de anticoagulación regional con citrato.

Info

Publication number
MX370297B
MX370297B MX2011013606A MX2011013606A MX370297B MX 370297 B MX370297 B MX 370297B MX 2011013606 A MX2011013606 A MX 2011013606A MX 2011013606 A MX2011013606 A MX 2011013606A MX 370297 B MX370297 B MX 370297B
Authority
MX
Mexico
Prior art keywords
patient
blood
dialysis
dialyzer
concentration
Prior art date
Application number
MX2011013606A
Other languages
English (en)
Other versions
MX2011013606A (es
Inventor
Peter Kotanko
Stephan Thijssen
Nathan W Levin
Original Assignee
Fresenius Medical Care Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Holdings Inc filed Critical Fresenius Medical Care Holdings Inc
Publication of MX2011013606A publication Critical patent/MX2011013606A/es
Publication of MX370297B publication Critical patent/MX370297B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3455—Substitution fluids
    • A61M1/3458—Substitution fluids having electrolytes not present in the dialysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A61M1/3675—Deactivation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • External Artificial Organs (AREA)

Abstract

Un procedimiento de realizar diálisis con anticoagulante regional con citrato de la sangre de un paciente incluye hacer circular la sangre desde y hacia el paciente por un circuito extracorporal que incluye un dializador que tiene membranas de diálisis semipermeables y una cámara de dializado que rodea las membranas. El procedimiento incluye además el hacer circular un dializado que contiene calcio y citrato por la cámara de dializado del dializador e introducir citrato en la sangre del paciente aguas arriba del dializador, por lo que se dializa la sangre del paciente. El procedimiento puede incluir además predecir la concentración de calcio ionizado sistémico en la sangre del paciente en cualquier momento en el tratamiento de diálisis o después de la diálisis, tal como por un modelo matemático. El procedimiento puede incluir además corregir estadísticamente la concentración después de la diálisis predicha preliminar de calcio ionizado sistémico en la sangre del paciente para proporcionar una concentración de calcio ionizado sistémico después de la diálisis predicha final.
MX2011013606A 2009-06-17 2010-06-17 Procedimientos de diálisis de anticoagulación regional con citrato. MX370297B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26887109P 2009-06-17 2009-06-17
US33554610P 2010-01-08 2010-01-08
PCT/US2010/038985 WO2010148194A1 (en) 2009-06-17 2010-06-17 Methods of regional citrate anticoagulation dialysis

Publications (2)

Publication Number Publication Date
MX2011013606A MX2011013606A (es) 2012-01-19
MX370297B true MX370297B (es) 2019-12-09

Family

ID=43356754

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013606A MX370297B (es) 2009-06-17 2010-06-17 Procedimientos de diálisis de anticoagulación regional con citrato.

Country Status (7)

Country Link
US (2) US8845571B2 (es)
EP (1) EP2442862B1 (es)
CN (1) CN102802719B (es)
AU (1) AU2010262902B2 (es)
CA (1) CA2764838C (es)
MX (1) MX370297B (es)
WO (1) WO2010148194A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102802719B (zh) 2009-06-17 2018-02-09 弗雷泽纽斯医疗保健控股有限公司 局部柠檬酸盐抗凝剂透析方法
DK2826476T3 (da) 2013-07-16 2021-03-22 G M T De Jong B V Calciumfrit dialysefluid
EP2959928A1 (fr) 2014-06-26 2015-12-30 Infomed SA Dispositif d'épuration du sang par circulation extracorporelle
EP3174572B1 (en) 2014-08-01 2018-09-26 Xenios AG Extracorporeal circuit for co2 removal from blood
DE102014011671B4 (de) * 2014-08-05 2023-12-28 Fresenius Medical Care Deutschland Gmbh Extrakoporale Blutbehandlungseinheit
DE102014113728B4 (de) 2014-09-23 2023-08-17 Fresenius Medical Care Deutschland Gmbh Verfahren und Vorrichtungen zum Vorbereiten eines extrakorporalen Blutkreislaufs für die Blutbehandlung
EP3015124B1 (en) * 2014-10-31 2017-08-16 B. Braun Avitum AG System for flexible citrate anticoagulation during extracorporeal blood treatment using feed-forward control
WO2016103216A1 (en) * 2014-12-23 2016-06-30 Universita' Degli Studi Di Milano - Bicocca Regional scoagulation system for an extracorporeal circulation circuit
DE102015015597A1 (de) 2015-12-04 2017-06-08 Fresenius Medical Care Deutschland Gmbh Behandlung von Schlaganfall durch Hämofiltration
ES2937293T3 (es) 2016-12-22 2023-03-27 Gambro Lundia Ab Aparato para el tratamiento de sangre extracorpóreo
US11167068B2 (en) 2016-12-22 2021-11-09 Gambro Lundia Ab Apparatus for extracorporeal blood treatment
CN110382018B (zh) * 2017-03-02 2022-04-29 旭化成医疗株式会社 血液净化装置
JP6811838B2 (ja) * 2017-03-02 2021-01-13 旭化成メディカル株式会社 血液浄化装置
US20210236710A1 (en) * 2018-04-19 2021-08-05 Texas Children's Hospital Physiologic cardiovascular ph balanced counter current electrolyte transfer and fluid removal system
JP2022534151A (ja) * 2018-12-11 2022-07-28 ガンブロ・ルンディア・エービー 局所クエン酸塩抗凝固療法の性能モニタリング
DE102019130432A1 (de) * 2019-11-12 2021-05-12 Fresenius Medical Care Deutschland Gmbh Steuer- oder Regelvorrichtung, User-Interface und Blutbehandlungsvorrichtung zum Ermitteln neuer Einstellwerte
CN113616204B (zh) * 2020-05-06 2024-06-11 上海交通大学医学院附属第九人民医院 一种可用于crrt的在线实时监测血液离子钙动态变化的装置

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941565A (en) * 1970-12-08 1976-03-02 Schwartz Henry D Clinical testing means and methods
JPS5225197B2 (es) * 1973-09-19 1977-07-06
US5437864A (en) * 1987-03-31 1995-08-01 The Scripps Research Institute Method of inhibiting blood coagulation in extracorporeal circulation by inhibiting human tissue factor
US5437861A (en) 1993-03-16 1995-08-01 Applied Immune Sciences, Inc. Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome
DE19654746C2 (de) * 1996-12-30 2000-05-11 Klaus Sodemann Dialyselösung
EP0986394B1 (en) 1997-06-05 2002-03-13 Global Hemostasis Institute MGR AB Anti-coagulation of blood, blood plasma or synovial fluid products
US6200287B1 (en) 1997-09-05 2001-03-13 Gambro, Inc. Extracorporeal blood processing methods and apparatus
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
EG24303A (en) * 1998-10-20 2009-01-12 Advanced Renal Technologies Buffered compositions for dialysis
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
PT1218039E (pt) * 1999-09-22 2009-05-25 Advanced Renal Technologies Utilização dum dialisado com alto teor de citrato
ATE523217T1 (de) 2000-03-09 2011-09-15 Caridianbct Inc Extrakorporale vorrichtung zur blutverarbeitung
DE10114283C2 (de) * 2000-12-22 2003-04-24 Fresenius Medical Care De Gmbh Verfahren zur Ermittlung der Ionenkonzentration des Blutes eines Patienten bei der citrat-antikoagulierten Hämodialyse und/oder Hämofiltration; Dialysegerät
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
US7351218B2 (en) 2002-12-20 2008-04-01 Gambro Lundia Ab Device and process for extracorporeal treatment by citrate anticoagulant
FR2848857B1 (fr) 2002-12-20 2005-09-16 Gambro Lundia Ab Dispositif et ligne a usage unique pour le traitement extracorporel du sang par anticoagulation au citrate
US7544301B2 (en) * 2004-08-19 2009-06-09 Hhd Llc Citrate-based dialysate chemical formulations
US20070270341A1 (en) 2005-09-06 2007-11-22 Paul Morley Parathyroid hormone analogues and methods of use
US8372025B2 (en) * 2005-09-22 2013-02-12 Baxter International Inc. Automation and optimization of CRRT treatment using regional citrate anticoagulation
JP2009509539A (ja) 2005-09-30 2009-03-12 パーレジェン サイエンシーズ， インコーポレイテッド 血糖調節の障害のスクリーニングおよび処置のための方法および組成物
US8133194B2 (en) * 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
JP5254043B2 (ja) * 2006-02-22 2013-08-07 ヘンリー フォード ヘルス システム 体外血液回路への局所クエン酸塩抗凝血剤送達システム及び方法
AT505690B1 (de) * 2007-08-31 2012-09-15 Zentrum Fuer Biomedizinische Technologie Der Donau Uni Krems Verfahren zum erfassen der ionenkonzentration bei citrat-antikoagulierter extrakorporaler blutreinigung
WO2010029401A2 (en) * 2008-09-09 2010-03-18 Gambro Lundia Ab A procedure and a device for extracorporeal blood treatment using citrate anticoagulation
AU2010230239B2 (en) * 2009-03-31 2014-08-07 Gambro Lundia Ab A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
CN102802719B (zh) 2009-06-17 2018-02-09 弗雷泽纽斯医疗保健控股有限公司 局部柠檬酸盐抗凝剂透析方法

Also Published As

Publication number Publication date
WO2010148194A1 (en) 2010-12-23
AU2010262902B2 (en) 2013-05-02
MX2011013606A (es) 2012-01-19
EP2442862B1 (en) 2020-09-30
US10525186B2 (en) 2020-01-07
CN102802719A (zh) 2012-11-28
US8845571B2 (en) 2014-09-30
US20140353251A1 (en) 2014-12-04
EP2442862A1 (en) 2012-04-25
CA2764838A1 (en) 2010-12-23
CN102802719B (zh) 2018-02-09
CA2764838C (en) 2018-05-01
US20110237996A1 (en) 2011-09-29
AU2010262902A1 (en) 2012-01-19
EP2442862A4 (en) 2018-04-04

Similar Documents

Publication Publication Date Title
MX370297B (es) Procedimientos de diálisis de anticoagulación regional con citrato.
GB2469950A (en) Dialysis system with recirculating dialysis fluid
WO2015184033A3 (en) Method for treating dialysate, dialysis system, and method for pre-evaluating dialysis patients for treatment with same
EP2324871A3 (en) Citrate anticoagulation system for extracorporeal blood treatments
MX2010004144A (es) Sistemas y metodos de arrastre y remocion de aire antes de un tratamiento de dialisis.
ATE420678T1 (de) Dialysemaschine mit einer einrichtung zur bestimmung der dialysedosis
EA201492106A1 (ru) Способ и устройство для контроля экстракорпоральной обработки крови пациента
Chan et al. Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes
IN2012DN00732A (es)
EP3015124B1 (en) System for flexible citrate anticoagulation during extracorporeal blood treatment using feed-forward control
WO2011106233A3 (en) Vibration-assisted dialysis methods
TW200833320A (en) Iron metabolism improving agent
NZ602996A (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
JP2014161605A (ja) 水素付加装置および腹膜透析装置
ATE316384T1 (de) Neue dialysemethode
WO2009152070A3 (en) Intradialytic administration of sodium thiosulfate
CN101744798A (zh) 一种含钙枸橼酸盐浓缩抗凝血液透析液
MX2007003120A (es) Metodo y composicion para el tratamiento de pacientes que se someten a dialisis de rinon.
Wester et al. A regenerable potassium and phosphate sorbent system to enhance dialysis efficacy and device portability: a study in awake goats
IT1395706B1 (it) Gruppo di emodiafiltrazione
UA122779U (uk) Спосіб лікування гострої серцевої недостатності у пацієнтів з гострим ідіоматичним гігантоклітинним міокардитом
Strobl et al. Preclinical Test of a Newly Developed Citrate Calcium Monitor
UA41042U (ru) Способ лечения ассоциированных урогенитальных инфекций
Senzel Various toxicities: case report
UA115241U (uk) Спосіб апаратного мембранного фільтраційного плазмаферезу при гострому некротизуючому панкреатиті

Legal Events

Date Code Title Description
FG Grant or registration